LGT Group Foundation
RDY icon

LGT Group Foundation’s Dr. Reddy's Laboratories RDY Stock Holding History

LGT Group Foundation’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$309K Hold
21,345
– – ﹤0.01% 258
2026
Q1 		$296K Hold
21,345
– – ﹤0.01% 253
2025
Q4 		$300K Hold
21,345
– – ﹤0.01% 263
2025
Q3 		$303K Hold
21,345
– – ﹤0.01% 253
2025
Q2 		$321K Hold
21,345
– – ﹤0.01% 254
2025
Q1 		$282K Buy
+21,345
New +$295K ﹤0.01% 261

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

LGT Group Foundation's RDY Position: Q2 2026 in Review

LGT Group Foundation held its Dr. Reddy's Laboratories (RDY) position steady in Q2 2026 at 21,345 shares worth $309K. The position accounts for ﹤0.01% of the portfolio, ranked #258.

LGT Group Foundation first reported a position in RDY in Q1 2025 and has held it in 6 quarters since. The position peaked at $321K in Q2 2025. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • LGT Group Foundation held 21,345 shares of Dr. Reddy's Laboratories worth $309K as of Q2 2026.
  • LGT Group Foundation left its Dr. Reddy's Laboratories share count unchanged in Q2 2026.
  • Dr. Reddy's Laboratories made up ﹤0.01% of LGT Group Foundation's portfolio in Q2 2026, its #258 holding.
  • LGT Group Foundation first reported a position in Dr. Reddy's Laboratories in Q1 2025 and has held it in 6 quarters since.
  • LGT Group Foundation's Dr. Reddy's Laboratories position peaked at $321K in Q2 2025.
  • 238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on LGT Group Foundation's 13F filing for Q2 2026, filed 10 Aug 2026.